SCHEMBL1228307

SCHEMBL1228307

COc1ccc(CCN2C(=O)C(=Cc3ccc(-c4ccc(OC)c(Cl)c4)o3)N=C2N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTRA2 O43464 1/20 0.47
▸ MAPT P10636 6/20 0.45
▸ MEN1 O00255 5/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ POLB P06746 4/20 0.45
▸ MCL1 Q07820 2/20 0.45
▸ PKM P14618 1/20 0.45
▸ PTPN7 P35236 1/20 0.45
▸ PTPN12 Q05209 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ PTPN22 Q9Y2R2 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.41
▸ MAP3K5 Q99683 1/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ RECQL P46063 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ PLA2G1B P04054 1/20 0.37
▸ DNMT1 P26358 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1228304 1.00 HTRA2 (0.47) HTRA2MAPTMEN1KMT2AALDH1A1
SCHEMBL1227354 0.92 MAPT (0.50) HTRA2MAPTMEN1KMT2AALDH1A1
SCHEMBL1227358 0.92 MAPT (0.50) HTRA2MAPTMEN1KMT2AALDH1A1
SCHEMBL1228154 0.88 HTRA2 (0.49) HTRA2MAPTMEN1KMT2AALDH1A1
SCHEMBL1228155 0.88 HTRA2 (0.49) HTRA2MAPTMEN1KMT2AALDH1A1
SCHEMBL1116054 0.88 HTRA2 (0.52) HTRA2MAPTMEN1KMT2AALDH1A1
SCHEMBL1116057 0.88 HTRA2 (0.52) HTRA2MAPTMEN1KMT2AALDH1A1
SCHEMBL1228316 0.87 HTRA2 (0.53) HTRA2MAPTMEN1KMT2AALDH1A1
SCHEMBL1228315 0.87 HTRA2 (0.53) HTRA2MAPTMEN1KMT2AALDH1A1
SCHEMBL1226763 0.86 HTRA2 (0.54) HTRA2MAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
Send feedback